Human umbilical cord blood mononuclear cells decrease fibrosis and increase cardiac function in cardiomyopathy

Regenerative Medicine

Volumn 5, Issue 1, 2010, Pages 45-54

  Henning, Robert J ^a   Aufman, Jeffrey ^a   Shariff, Masood ^a   Sawmiller, Darrell ^a   Delostia, Vincent ^a   Sanberg, Paul ^a   Morgan, Michael ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cardiomyopathy; Left ventricular ejection fraction; Umbilical cord blood stem cells; Ventricular fibrosis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ECHOCARDIOGRAPHY; HAMSTER; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SHORT COURSE THERAPY; THERAPY EFFECT;

ANIMALS; CARDIOMYOPATHIES; CORD BLOOD STEM CELL TRANSPLANTATION; CRICETINAE; FETAL BLOOD; FIBROSIS; HEART; HUMANS; LEUKOCYTES, MONONUCLEAR; STROKE VOLUME; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77649288740     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.09.71     Document Type: Article

References (39)

1. Murry CE, Field LJ, Menasche P: Cell-based cardiac repair: reflections at the 10 year point. Circulation 112, 3174-3183 (2005).
2. Murry CE, Reinecke H, Pabon LM: Regeneration gaps: observations on stem cells and cardiac repair. J. Am. Coll. Cardiol. 47, 1777-1785 (2006).
3. Chambers SM: Aging stem cells decline in function and exhibit dysregulation. PLoS Biol. 5, 1750-1762 (2007).
4. Rota M, LeCapitaine N: Diabetes promotes stem cell aging and heart failure. Circ. Res. 99, 42-52 (2006).
5. Henning RJ, Abu-Ali H, Balis JB: Human umbilical cord stem cells in the treatment of acute myocardial infarction. Cell Transplant. 13, 729-739 (2004).
6. Henning RJ, Burgos JD, Ondrovic L: Human umbilical cord stem cells are attracted to infarcted hearts. Cell Transplant. 15, 647-658 (2006).
7. Henning RJ, Burgos JD, Vasko M: Human umbilical cord stem cells and myocardial infarction: effect of dose and route of administration on infarct size. Cell Transplant. 16, 907-917 (2007)
8. Henning RJ, Alvarado F, Shariff M, Vasko M: Human cord blood mononuclear cells decrease cytokines and Inflammatory cells in acute infarcts. Stem Cells Dev. 7, 207-1220 (2008).
9. Broxmeyer HE: Cord Blood: Biology, Immunology, Banking and Clinical Transplantation. AABB Press, Bethesda, MD, USA (2004).
10. Lee O, Kuo T, Chen W-M, Lee K-D, Hsieh S-L, Chen T-H: Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103, 1669-1675 (2004).
11. Gluckman E: Ten years of cord blood transplantation: from bench to bedside. Br. J. Haematol. 147, 192-199 (2009).
12. Vendrame M, Cassady J, Newcomb J et al.: Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35, 2390-2395 (2004).
13. Pesce M, Orlandi A, Lachininoto MG et al..: Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ. Res. 93, e51-e62 (2003).
14. Murohora T, Ikeda H, Duan J et al..: Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105, 1527-1536 (2000).
15. Kawada T, Nakatsuru Y, Sakamoto A et al.: Stain and age dependent loss of sarcoglycan complex in cardiomyopathic hamster hearts and its re-expression by d-sarcoglycan gene transfer in vivo. FEBS Lett. 458, 405-408 (1999).
16. Feigenbaum H, Armstrong W: Echocardiography. Lippincott Williams & Wilkins, USA (2004).
17. Wu KH, Mo XM, Zhou B et al.: Cardiac potential of stem cells from whole umbilical cord tissue. J. Cell. Biochem. 7, 926-932 (2009).
18. Nunes VA, Cavacana N, Canovas M et al.: Stem cells from umbilical cord blood differentiate into myotubes and express dystrophin in vitro only after exposure to in-vivo muscle environment. Biol. Cell 99, 185-186 (2007).
19. Jazedje T, Secco M, Vieira NM, Zucconi E: Stem cells from umbilical cord blood do have myogenic potential with and without differentiation. J. Transl. Med. 7, 6 (2009).
20. Kong KY, Ren J, Kraus M, Finklestein SP, Brown RH: Human umbilical cord blood cells differentiate into muscle in sjl muscular dystrophy mice. Stem Cells 22(6), 981-993 (2004).
21. Ohno N, Fedak P, Weisel R, Mickle D, Fugii T, Li R-K: Transplantation of cryopreserved muscle cells in dilated cardiomyopathy: effects on left ventricular geometry and function. J. Thor. Cardiovasc. Surg. 126, 1537-1548 (2003).
22. Forrester JS, Shah PK, Makkar RR: Myocardial regeneration by stem cells: seeing the unseeable. J. Am. Coll. Cardiol. 48, 1722-1724 (2006).
23. Murohara T, Ikeda H, Duan J et al..: Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105, 1527-1536 (2000).
24. Hirata Y, Sata M, Motomura N et al.: Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem. Biophys. Res. Comm. 327, 609-614 (2005).
25. Ma N, Stamm C, Kaminski A, Li W, Kleine HD: Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc. Res. 66, 45-54 (2005).
26. Chen H, Hung H, Shyu K et al..: Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after myocardial infarction. Eur. J. Clin. Invest. 35, 677-686 (2005).
27. Ziegelhoeffer T, Bernandez B, Kostin S et al..: Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 94, 230-238 (2004).
28. Pomyje J, Zivny J, Sefc L, Plasilova M, Pytlik R, Necas E: Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells. Eur. J. Haematol. 70, 143-150 (2003).
29. Wheeler M, Allikian M, Heydemann A, Hadhazy M, Zarnegar S, McNally E: Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy. J. Clin. Invest. 113, 668-675 (2004).
30. Vendrame M, Gemma C, Mesquita D et al.: Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 14, 595-604 (2005).
31. Villasensor-Bustamante S: Role of IL-10 in autoantibody production and in the fate of human cord blood CD5+ B lymphocytes. Scan. J. Immunol. 85, e17-e24 (1999).
32. Rainsford E, Reen DJ: IL-10 produced by human newborn T cells may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br. J. Haematol. 116, 702-709 (2002).
33. Vendrame M, Gemma C, Pennypacker KR et al..: Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp. Neurol. 199, 191-200 (2006).
34. Moore KW, De Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immun. 19, 683-765 (2001).
35. Godfrey WR, Spoden DJ, Ge YG et al.: Cord blood CD4 CD25+ derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 105, 750-758 (2005).
36. Zhao Y, Huang Z, Qi M, Lazzarini P, Mazzone T: Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell. Immunol. Lett. 108, 78-87 (2007).
37. Gnecchi M, He H, Liang O, Melo L et al.: Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11, 367-368 (2005).
38. Ohnisi S, Sumiyoshi S, Kitamura N, Nagaya N: Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett. 581, 3961-3966 (2007)
39. Shabbir A, Zisa D, Suzuki G, Lee T: Heart failure therapy mediated by the trophic activities of bone marrow mesencymal stem cells: a noninvasive therapeutic regimen. Am. J. Physiol. Heart Circ. Physiol. 296, H1888-H1897 (2009).